GSK Ownership | Who Owns GSK?
GSK Ownership Summary
GSK is owned by 2.80% institutional investors, 0.12% insiders, and 97.07% retail investors. Dodge & cox is the largest institutional shareholder, holding 1.68% of GSK shares. Dodge & Cox Stock I is the top mutual fund, with 2.45% of its assets in GSK shares.
GSK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | GSK | 2.80% | 0.12% | 97.07% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Drug Manufacturers - General Stocks | 45.98% | 1.80% | 52.22% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Dodge & cox | 68.44M | 1.68% | $2.31B |
| Fmr | 52.82M | 1.29% | $1.79B |
| Primecap management co/ca/ | 25.26M | 0.62% | $854.35M |
| Jtc employer solutions trustee | 20.28M | 0.50% | $682.27M |
| Fisher asset management | 18.84M | 0.46% | $637.06M |
| Morgan stanley | 10.11M | 0.25% | $389.18M |
| Goldman sachs group | 9.68M | 0.24% | $327.48M |
| Price t rowe associates inc /md/ | 7.57M | 0.19% | $255.91M |
| Royal bank of canada | 7.17M | 0.18% | $242.46M |
| State street | 6.80M | 0.17% | $264.46M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Jtc employer solutions trustee | 20.28M | 48.38% | $682.27M |
| Eversept partners, lp | 3.66M | 10.99% | $123.84M |
| Callodine capital management, lp | 700.00K | 4.89% | $23.67M |
| Mondrian investment partners | 5.84M | 3.40% | $205.92M |
| Kempner capital management | 183.08K | 3.40% | $6.19M |
| Equity investment | 3.96M | 3.14% | $134.01M |
| Hillman capital management | 195.13K | 2.65% | $7.51M |
| Keystone financial planning | 227.91K | 2.39% | $7.71M |
| Stamos capital partners | 294.82K | 2.34% | $9.97M |
| Clean yield group | 200.06K | 2.15% | $6.77M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 52.82M | 0.11% | 23.81M |
| Primecap management co/ca/ | 25.26M | 0.66% | 10.41M |
| Ubs group | 6.48M | 0.04% | 5.82M |
| Goldman sachs group | 9.68M | 0.05% | 2.31M |
| Voloridge investment management | 2.17M | 0.26% | 2.02M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Provident trust | - | - | -3.95M |
| Arrowstreet capital, limited partnership | 218.26K | 0.01% | -3.65M |
| Acadian asset management | 1.32M | 0.13% | -2.75M |
| Hsbc | 11.18K | 0.00% | -2.55M |
| Morgan stanley | 10.11M | 0.03% | -2.36M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Raymond james financial | 1.38M | 0.02% | 1.38M | $46.78M |
| Woodline partners lp | 1.08M | 0.25% | 1.08M | $36.67M |
| Auto-owners insurance | 923.00K | 0.71% | 923.00K | $31.22M |
| Miller howard investments inc /ny | 690.90K | 0.77% | 690.90K | $23.37M |
| Bnp paribas arbitrage, snc | 367.31K | 0.01% | 367.31K | $12.42M |
Sold Out
| Holder | Change |
|---|---|
| Northwest financial advisors | -1.00 |
| West branch capital | -7.00 |
| Aspire private capital | -7.00 |
| Operose advisors | -11.00 |
| Cedar mountain advisors | -17.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 507 | -44.83% | 114,357,926 | -62.96% | 2 | 1.22% | 223 | -43.97% | 181 | -42.54% |
| Sep 30, 2024 | 907 | 1.80% | 308,475,315 | -0.74% | 15 | 6.51% | 392 | 2.08% | 310 | 2.99% |
| Jun 30, 2024 | 873 | -5.72% | 308,017,843 | -1.01% | 7 | 12.95% | 377 | -11.71% | 293 | -2.01% |
| Mar 31, 2024 | 926 | 1.76% | 311,145,368 | 7.01% | 7 | 14.88% | 427 | 7.29% | 299 | -9.67% |
| Dec 31, 2023 | 910 | 5.20% | 290,762,598 | 1.94% | 7 | 14.49% | 398 | 1.27% | 331 | 22.14% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Dodge & Cox Stock I | 50.00M | 2.45% | -49.90K |
| Vanguard PRIMECAP Inv | 17.92M | 0.88% | 7.56M |
| Strategic Advisers Fidelity US TtlStk | 7.19M | 0.35% | 210.10K |
| GMO Intl Op Value Composite | 7.03M | 0.35% | 7.03M |
| Dodge & Cox Balanced I | 4.80M | 0.24% | - |
| Dodge & Cox Balanced Composite | 4.80M | 0.24% | - |
| Fidelity Series Value Discovery | 4.45M | 0.22% | - |
| T. Rowe Price International Val Eq Tr- A | 3.89M | 0.19% | 77.59K |
| Fidelity Series Large Cap Stock | 3.81M | 0.19% | 277.30K |
| T. Rowe Price International Value Eq | 3.14M | 0.15% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2023 Q1 | - | - |
| 2022 Q4 | - | - |
| 2021 Q3 | 1 | - |
| 2021 Q2 | - | - |
| 2018 Q3 | 1 | - |
GSK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools